Big things are happening recently with Creso Pharma (ASX: CPH) (OTC: COPHF) (FRA: 1X8), most notably the closing of the company's acquisition of Canadian psychedelics firm Halucenex Life Sciences and... read more →
With the Halucenex Life Sciences Acquisition Now a Done Deal, Creso Pharma Will Look to Capitalize on the Rapidly Emerging Global Medical Psychedelics Market Currently Valued at Up to USD... read more →
Welcome to the Cannabis Countdown, the Legal Marijuana Industry’s Number One Curated Weekly News Recap. In This Week’s Edition, We Recap and Countdown the Top 10 Cannabis and Psychedelic Stock News... read more →
Creso Pharma Informed Shareholders That Due Diligence on the Company's Acquisition of Psychedelics Firm Halucenex Life Sciences Continues to Move Forward in a Positive Direction Also, Creso Announced That Halucenex... read more →
Broadly, the cannabis industry can be broken down into four sectors; 1) cannabis sellers (Canadian licensed producers, American multi and single state operators, etc.), 2) business-to-business (sellers of lighting, soil,... read more →
As a Result of the Pandemic, Mental Illness is on the Rise and With a Severe Lack of Treatment Options, the Medicinal Psychedelics Industry Has Experienced Exponential Growth With Some... read more →
